71.77
price up icon4.01%   2.77
pre-market  시장 영업 전:  70.53   -1.24   -1.73%
loading
전일 마감가:
$69.00
열려 있는:
$67.62
하루 거래량:
1.81M
Relative Volume:
1.37
시가총액:
$7.61B
수익:
$628.56M
순이익/손실:
$141.82M
주가수익비율:
56.96
EPS:
1.26
순현금흐름:
$142.60M
1주 성능:
+3.79%
1개월 성능:
-0.69%
6개월 성능:
+7.26%
1년 성능:
+103.31%
1일 변동 폭
Value
$66.46
$71.91
1주일 범위
Value
$62.40
$71.91
52주 변동 폭
Value
$32.33
$117.33

코르셉트 테라퓨틱스 Stock (CORT) Company Profile

Name
명칭
Corcept Therapeutics Inc
Name
전화
650.688.8803
Name
주소
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Name
직원
500
Name
트위터
Name
다음 수익 날짜
2025-02-17
Name
최신 SEC 제출 서류
Name
CORT's Discussions on Twitter

CORT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CORT
Corcept Therapeutics Inc
71.77 7.27B 628.56M 141.82M 142.60M 1.26
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 118.67B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
571.54 59.23B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
419.56 52.67B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
690.32 41.24B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
304.30 32.36B 3.81B -644.79M -669.77M -6.24

코르셉트 테라퓨틱스 Stock (CORT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-11-06 업그레이드 Truist Hold → Buy
2023-04-11 개시 SVB Securities Market Perform
2023-04-04 개시 Piper Sandler Overweight
2023-02-15 다운그레이드 Jefferies Buy → Hold
2022-08-01 다운그레이드 Truist Buy → Hold
2022-07-27 업그레이드 Jefferies Hold → Buy
2022-06-27 재개 Canaccord Genuity Buy
2022-02-02 개시 Canaccord Genuity Buy
2022-01-28 개시 Truist Buy
2020-08-05 다운그레이드 Jefferies Buy → Hold
2019-09-24 개시 Jefferies Buy
2019-09-06 개시 H.C. Wainwright Buy
2019-02-04 다운그레이드 B. Riley FBR Buy → Neutral
2018-08-10 재확인 Stifel Hold
2018-05-31 다운그레이드 Stifel Buy → Hold
2018-03-09 개시 B. Riley FBR, Inc. Buy
2017-08-31 개시 Stifel Buy
2017-02-02 개시 Ladenburg Thalmann Buy
2015-04-21 개시 FBR Capital Outperform
2014-01-13 다운그레이드 Stifel Buy → Hold
2013-08-09 다운그레이드 Janney Buy → Neutral
2013-08-09 다운그레이드 Ladenburg Thalmann Buy → Neutral
2012-02-21 재확인 JMP Securities Mkt Outperform
2010-01-06 업그레이드 Ladenburg Thalmann Neutral → Buy
2008-07-17 개시 Rodman & Renshaw Mkt Outperform
2007-06-21 업그레이드 Punk, Ziegel & Co Mkt Perform → Accumulate
모두보기

코르셉트 테라퓨틱스 주식(CORT)의 최신 뉴스

pulisher
Aug 04, 2025

Cushings Syndrome Market Exclusive Report with Detailed Study - openPR.com

Aug 04, 2025
pulisher
Aug 03, 2025

How does Corcept Therapeutics Incorporated compare to its industry peersLightning-fast growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Corcept Therapeutics Incorporated company’s balance sheetTriple-digit wealth increases - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Corcept Therapeutics Incorporated stock compared to the marketGet professional advice for market timing - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Corcept Therapeutics Analyst Rating Update: Canaccord Genuity Maintains 'Buy' Rating with Lowered Price Target to 137.00 USD - AInvest

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Corcept Therapeutics Incorporated stock higher in 2025Dynamic profit opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Why is Corcept Therapeutics Incorporated stock attracting strong analyst attentionFastest return on investment - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the latest earnings results for Corcept Therapeutics IncorporatedInvest smarter with daily stock recommendations - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Corcept Therapeutics Incorporated stockRealize exceptional returns through smart trading - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

CORT's Q2 Earnings Beat and Pipeline Momentum: A Case for Revisiting the Downside as a Buy Opportunity - AInvest

Aug 02, 2025
pulisher
Aug 02, 2025

When is Corcept Therapeutics Incorporated stock expected to show significant growthTremendous financial leverage - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Corcept Therapeutics (CORT): A High-Conviction Buy Amidst Breakthroughs in Cortisol-Modulating Therapies - AInvest

Aug 02, 2025
pulisher
Aug 02, 2025

Corcept Therapeutics Incorporated (NASDAQ:CORT) Q2 2025 Earnings Call Transcript - Insider Monkey

Aug 02, 2025
pulisher
Aug 02, 2025

Corcept Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Aug 02, 2025
pulisher
Aug 01, 2025

Published on: 2025-08-02 05:25:16 - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

Corcept Therapeutics’ Earnings Call: Growth Amid Challenges - TipRanks

Aug 01, 2025
pulisher
Aug 01, 2025

Corcept Therapeutics Incorporated Recovery Hinges on Volume BreakoutNews Based Entry Opportunity Alerts Detected - metal.it

Aug 01, 2025
pulisher
Aug 01, 2025

CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut, Stock Down - TradingView

Aug 01, 2025
pulisher
Aug 01, 2025

A Quick Look at Today's Ratings for Corcept Therapeutics(CORT.US), With a Forecast Between $121 to $145 - 富途牛牛

Aug 01, 2025
pulisher
Aug 01, 2025

Corcept Therapeutics 2025 Q2 Earnings Misses Targets as Net Income Declines 1% - AInvest

Aug 01, 2025
pulisher
Aug 01, 2025

Corcept Faces Growing Pains As Earnings Miss The Mark - Finimize

Aug 01, 2025
pulisher
Aug 01, 2025

Corcept Therapeutics Q2 CY2025: Revenue Misses, Earnings BeatNews and Statistics - IndexBox

Aug 01, 2025
pulisher
Aug 01, 2025

Corcept: Q2 Earnings Snapshot - Connecticut Post

Aug 01, 2025
pulisher
Jul 31, 2025

Earnings call transcript: Corcept Therapeutics Q2 2025 earnings beat expectations By Investing.com - Investing.com Canada

Jul 31, 2025
pulisher
Jul 31, 2025

Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Corcept (NASDAQ:CORT) Misses Q2 Sales Targets - Yahoo Finance

Jul 31, 2025
pulisher
Jul 31, 2025

Corcept Therapeutics Reports Strong Q2 Earnings, Surpassing Analyst ExpectationsNews and Statistics - IndexBox

Jul 31, 2025
pulisher
Jul 31, 2025

Corcept Therapeutics falls as revenue guidance disappoints investors By Investing.com - Investing.com Canada

Jul 31, 2025
pulisher
Jul 31, 2025

Corcept Therapeutics Reports Q2 2025 Financial Results - TipRanks

Jul 31, 2025
pulisher
Jul 31, 2025

CORCEPT THERAPEUTICS INC SEC 10-Q Report - TradingView

Jul 31, 2025
pulisher
Jul 31, 2025

Corcept Earnings: Record Patient Growth Drives 19% Revenue Jump, Pipeline Scores Multiple Wins - Stock Titan

Jul 31, 2025
pulisher
Jul 31, 2025

Insiders Favor These 3 High Growth Companies - Yahoo.co

Jul 31, 2025
pulisher
Jul 31, 2025

Corcept Therapeutics Announces Q2 Financial Results and Corporate Update on July 31, 2025 - AInvest

Jul 31, 2025
pulisher
Jul 30, 2025

Corcept Therapeutics Advances Long-Term Safety Study of Relacorilant for Cushing Syndrome - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Corcept Therapeutics' Q2 Earnings: A Critical Inflection Point for Growth and Innovation - AInvest

Jul 29, 2025
pulisher
Jul 29, 2025

What To Expect From Corcept’s (CORT) Q2 Earnings - Yahoo.co

Jul 29, 2025
pulisher
Jul 29, 2025

Technical Charts Suggest Momentum Shift in Corcept Therapeutics IncorporatedSmart Allocation Stock Pick Insights Gaining Interest - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

Published on: 2025-07-28 23:53:14 - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Corcept Therapeutics’ MOMENTUM Study: A Closer Look at Hypercortisolism in Resistant Hypertension - TipRanks

Jul 28, 2025
pulisher
Jul 28, 2025

Why Corcept Therapeutics Incorporated stock attracts strong analyst attentionPortfolio Diversification Stock Ideas From Experts - beatles.ru

Jul 28, 2025
pulisher
Jul 28, 2025

Why Corcept Therapeutics Incorporated stock attracts strong analyst attention Daily Equity Signal Strength Summary Report - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

What are the technical indicators suggesting about Corcept Therapeutics IncorporatedInvest confidently with professional market insights - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

H.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT) - Yahoo Finance

Jul 28, 2025
pulisher
Jul 27, 2025

Corcept Therapeutics Advances Pipeline Fueling Growth With Controlled Risk - Yahoo Finance

Jul 27, 2025
pulisher
Jul 25, 2025

10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey

Jul 25, 2025
pulisher
Jul 25, 2025

Corcept Therapeutics’ ALS Study: A Potential Game-Changer? - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

Should I buy Corcept Therapeutics Incorporated stock before earningsHigh-octane financial growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Is Corcept Therapeutics Incorporated a good long term investmentConsistent high-performance stocks - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What drives Corcept Therapeutics Incorporated stock priceUnbelievable profit margins - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Is Corcept Therapeutics Incorporated stock overhyped or has real potentialFree Market Dynamics Reports - jammulinksnews.com

Jul 25, 2025

코르셉트 테라퓨틱스 (CORT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$78.04
price up icon 3.24%
$37.88
price up icon 2.07%
$111.24
price up icon 2.35%
$29.32
price up icon 8.31%
$110.03
price up icon 2.51%
biotechnology ONC
$304.30
price up icon 1.77%
자본화:     |  볼륨(24시간):